AGREEMENT
EXHIBIT
2
AGREEMENT
In
accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934,
as
amended, the undersigned hereby agree that this Statement on Schedule 13D
relating to the Common Stock, $0.01 par value, of Biocryst Pharmaceuticals,
Inc.
is being filed with the Securities and Exchange Commission on behalf of each
of
them.
|
Date: August
8, 2007
|
By: | /s/ Xxxxxx X. Xxxxx |
|
Xxxxxx X. Xxxxx |
||
| By: | /s/ Xxxxx X. Xxxxx | |
|
Xxxxx X. Xxxxx |
||
